PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -75.22M | -78.34M | -77.74M | -82.71M | -80.87M |
| Total Depreciation and Amortization | 122.00K | 130.00K | 133.00K | 139.00K | 479.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.65M | 3.43M | 3.12M | 7.17M | 7.32M |
| Change in Net Operating Assets | 180.00K | -208.00K | 914.00K | 2.35M | 3.01M |
| Cash from Operations | -71.27M | -74.99M | -73.58M | -73.05M | -70.07M |
| Capital Expenditure | -14.00K | -25.00K | -29.00K | -70.00K | -72.00K |
| Sale of Property, Plant, and Equipment | 1.00K | 31.00K | 31.00K | 253.00K | 281.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.08M | 62.28M | 70.17M | 59.29M | 64.35M |
| Cash from Investing | 39.07M | 62.28M | 70.17M | 59.47M | 64.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 535.00K | 495.00K | 505.00K | 285.00K | 285.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 535.00K | 495.00K | 505.00K | 285.00K | 285.00K |
| Foreign Exchange rate Adjustments | 3.00K | 2.00K | 7.00K | -3.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.66M | -12.21M | -2.89M | -13.30M | -5.22M |